Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Neovasc Inc. T.NVCN

Alternate Symbol(s):  NVCN

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina.


Opinion & Analysis (TSX:NVCN)

    The Medical Device Co. That’s on the Cutting-Edge of Advancing Heart Disease Treatment

    Dave Jackson November 30, 2021

    Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

    Streetwise Reports January 3, 2020

    Buzz on the Bullboards: Big News With ACB and ISOL

    Stockhouse Editorial April 13, 2018